In erdafitinib-resistant bladder cancer cells, high levels of prolyl 4-hydroxylase subunit alpha 2 (P4HA2) stabilize hypoxia inducible factor 1α (HIF-1α), which activates downstream target genes and lowers ROS levels in bladder cancer [53]. This evidence concerns the gene HIF1A and urinary bladder cancer.